Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

  • Pharmacists could be able to prescribe 'low-risk' drugs under new legislation

    Pharmacists could be given powers to prescribe medicines in low-risk situations as part of new legislation being put forward by the government.

    The Medicines and Medical Devices Bill 2019/2020, which was first announced in the Queen’s Speech in December 2019 and was introduced by the Department of Health and Social Care (DHSC) on 13 February 2020, would also enable hospitals to use patient DNA to manufacture tailor-made drugs in an effort to improve access to treatments for patients with rare cancers and brain tumours.

    It follows plans set out in the October 2019 Queen’s Speech to introduce legislation to allow a wider range of healthcare professionals in the NHS to prescribe ‘low-risk’ medicines.

    A DHSC statement published alongside the Bill said the legislation will “allow the sector to increase the range of professions able to prescribe medicines in low-risk circumstances, as midwives and paramedics do now with pain relief, and physiotherapists with anti-inflammatories”.

    “This will be with appropriate safeguards and clear limits on what medications are eligible,” it added.

    The DHSC confirmed to The Pharmaceutical Journal that the list of healthcare professionals given the powers to prescribe these types of medicines could “potentially” include pharmacists, subject to a consultation.

    It added that the definition of ‘low-risk’ circumstances would be consulted on.

    “This allows the NHS to make the very best use of its highly skilled workforce, to save patients’ time and reduce unnecessary GP appointments,” the statement added.

    Sandra Gidley, president of the Royal Pharmaceutical Society, said: “Given that pharmacists have greater expertise in drug use than any other profession, this would appear to be a good move.

    “We have yet to see the detail, but thought should also be given as to how to make better use of pharmacy independent prescribers in community settings.”

    The new legislation will also enable hospitals to use patient tissue and DNA samples “to tailor innovative treatments for individual patients when other medicines have failed,” the DHSC said.

    It also said the bill will allow hospitals, in their existing facilities, “to develop drugs that have a shelf-life of minutes and wouƒld otherwise be unavailable to them”.

    “This has the potential to streamline access to treatments for patients with rare cancers and brain tumours.”

    Aamer Safdar, pharmacy education, training and workforce development team lead at Barts Health NHS Trust, told The Pharmaceutical Journal that the new legislation “is good news for patients and for researchers as it will allow innovation in the growing area of personalised medicines”.

    The government’s impact assessment of the Bill, published the week after the Bill, paves the way towards allowing legally separate pharmacies to set up shared hub-and-spoke dispensing services

    It said the Bill would enable secondary legislation that would allow large multiple pharmacies with existing dispensing hubs to “expand their capacity” and “offer chargeable prescription assembly services to independent and small multiple pharmacies”.

    Previous government proposals to introduce cross-firm hub-and-spoke dispensing in 2016 were shelved after pharmacy bodies expressed concern over the safety of the plans.

    However, in its impact assessment of the medicines Bill, the government noted that the “the costs and benefits [of the model] remain uncertain, as do some details around the policy design”.

    Any secondary legislation to implement hub-and-spoke dispensing is expected to be “accompanied by a full economic appraisal”, it said.


  • pause slideshow

Computer, digital electronic prescribing, pharmacy

Government announces digital hospital-to-pharmacy referral service to cut hospital readmissionsSubscription

Hospitals will be able to digitally refer recently discharged patients to community pharmacies across England for advice on new and updated prescriptions from July 2020.

PSA performance review of the General Pharmaceutical Council

Pharmacy regulator fails four in ten fitness-to-practise standards in watchdog reportSubscription

The General Pharmaceutical Council has failed to meet four out of ten fitness-to-practise standards set by the Professional Standards Authority, an annual review has found.

Erythromycin packet

Warnings over macrolides in early pregnancy after research shows risk of birth defectsSubscription

Macrolide antibiotics should be used “with caution” in early pregnancy, researchers who found an associated increased risk of major birth defects have warned.

Older people painting together

Almost 40% of hospitals do not offer non-drug therapies to distressed dementia patientsSubscription

Nearly 40% of acute trusts in England do not offer any non-pharmacological therapies to help manage symptoms such as distress, aggression and agitation in patients with dementia while they are in hospital, The Pharmaceutical Journal can reveal.

Older woman on their own in their home

Pharmacy delivery drivers to be trained to spot loneliness in older patientsSubscription

Community pharmacy drivers who deliver prescriptions to patients’ homes are to be trained to spot signs of loneliness and isolation in frail older people in a pilot being developed in Wales.

Codeine packet

Codeine should not be available over the counter, says chair of opioid expert working groupSubscription

Low-dose codeine should no longer be available to buy over the counter, the chair of the UK’s Commission on Human Medicines opioid expert working group has said.

All News

Child having a blood test

Weight may affect routine blood test results in children, researchers saySubscription

A child’s weight may influence the results of many routine blood tests, research published in the Journal of Clinical Endocrinology & Metabolism has suggested

Woman undergoing radiotherapy

Step counting can help predict outcomes for patients undergoing lung cancer treatment Subscription

Measuring patients’ step counts before they receive lung cancer treatment could help predict outcomes, research published in the International Journal of Radiation Oncology, Biology, Physics has suggested.

Nutritionist interviewing a patient

Low-intensity intervention ineffective at reducing cardiovascular riskSubscription

A low-intensity psychological intervention did not improve physical activity and weight loss in people at risk of cardiovascular disease events, a study published in Heart has shown.

Teenagers eating ultra-processed food

Consumption of ultra-processed foods linked to diabetes riskSubscription

Consuming greater proportions of ultra-processed foods is associated with an increased risk of type 2 diabetes, results of a prospective cohort study have suggested.

Community pharmacy consultation

Patients taking anticoagulants feel excluded from therapy decisionsSubscription

Patients with atrial fibrillation report several negative experiences associated with changes to their anticoagulation therapy — something that shared decision-making and patient education could help to address, research has suggested.

Trials of HPV vaccine may have overestimated its efficacy study finds

Trials of HPV vaccine may have overestimated its efficacy, study findsSubscription

The efficacy of human papillomavirus vaccines as a preventative for cervical cancer may have been overestimated in trials, a review in the Journal of the Royal Society of Medicine has concluded.

All Science